Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 26Thoracic 23CNS 23Sarcoma 5Other solid neoplasm 3Genitourinary 3Tumor-Agnostic 2Other hematologic neoplasm 2Gastrointestinal 2Myeloid 1Lymphoid 1Endocrine 1Dermatologic 1Breast 1

Conditions

Retinoblastoma 2Retinal Neoplasms 1Pediatric Brain Tumor 1Eye Neoplasms 1

Interventions

pembrolizumab 77Injections 67Carboplatin 37Nivolumab 32Pemetrexed 29Cisplatin 29Cyclophosphamide 25Specimen Handling 23Interviews as Topic 23tislelizumab 20atezolizumab 20Bevacizumab 20Paclitaxel 19fludarabine 16Standard of Care 16Practice Guidelines as Topic 16Docetaxel 16Ipilimumab 15toripalimab 14Educational Status 14Cetuximab 14Fluorouracil 13Oxaliplatin 12Etoposide 12olaparib 11durvalumab 11Methods 11Gemcitabine 11Early Intervention, Educational 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Topotecan × Other solid neoplasm × 1 year × Clear all
NCT05521984 2026-04-02

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Washington University School of Medicine

Phase 1 Recruiting
20 enrolled
Other solid neoplasm

Pediatric Brain Tumor

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting
225 enrolled
Other solid neoplasm

Retinoblastoma

NCT00186888 2025-09-04

Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

St. Jude Children's Research Hospital

Phase 3 Completed
107 enrolled 34 charts
Other solid neoplasm

Eye Neoplasms, Retinoblastoma, Retinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡